Mitochondrial Dysfunction and Decreased Cytochrome Ic/I in Cell and Animal Models of Machado–Joseph Disease

• Published in: Cells (Basel, Switzerland) Vol. 12; no. 19
• Main Authors: Almeida, Filipa, Ferreira, Ildete L, Naia, Luana, Marinho, Daniela, Vilaça-Ferreira, Ana Catarina, Costa, Marta D, Duarte-Silva, Sara, Maciel, Patrícia, Rego, A. Cristina
• Format: Journal Article
• Language: English
• Published: MDPI AG 01-10-2023
• Subjects: Analysis; Care and treatment; Cerebellar ataxia; Cytochromes; Diagnosis; Genetic aspects; Genetic markers; Mitochondrial diseases; Portugal
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12192397

Mitochondrial dysfunction has been described in many neurodegenerative disorders; however, there is less information regarding mitochondrial deficits in Machado–Joseph disease (MJD), a polyglutamine (polyQ) disorder caused by CAG repeat expansion in the ATXN3 gene. In the present study, we characterized the changes in mitochondrial function and biogenesis markers in two MJD models, CMVMJD135 (MJD135) transgenic mice at a fully established phenotype stage and tetracycline-regulated PC6-3 Q108 cell line expressing mutant ataxin-3 (mATXN3). We detected mATXN3 in the mitochondrial fractions of PC6-3 Q108 cells, suggesting the interaction of expanded ATXN3 with the organelle. Interestingly, in both the cerebella of the MJD135 mouse model and in PC6-3 Q108 cells, we found decreased mitochondrial respiration, ATP production and mitochondrial membrane potential, strongly suggesting mitochondrial dysfunction in MJD. Also, in PC6-3 Q108 cells, an additional enhanced glycolytic flux was observed. Supporting the functional deficits observed in MJD mitochondria, MJD135 mouse cerebellum and PC6-3 Q108 cells showed reduced cytochrome c mRNA and protein levels. Overall, our findings show compromised mitochondrial function associated with decreased cytochrome c levels in both cell and animal models of MJD.